The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Abstract
The past decade has witnessed hundreds of reports declaring or refuting genetic association with putative Alzheimer disease susceptibility genes. This wealth of information has become increasingly difficult to follow, much less interpret. We have created a publicly available, continuously updated database that comprehensively catalogs all genetic association studies in the field of Alzheimer disease (http://www.alzgene.org). We performed systematic meta-analyses for each polymorphism with available genotype data in at least three case-control samples. In addition to identifying the epsilon4 allele of APOE and related effects, we pinpointed over a dozen potential Alzheimer disease susceptibility genes (ACE, CHRNB2, CST3, ESR1, GAPDHS, IDE, MTHFR, NCSTN, PRNP, PSEN1, TF, TFAM and TNF) with statistically significant allelic summary odds ratios (ranging from 1.11-1.38 for risk alleles and 0.92-0.67 for protective alleles). Our database provides a powerful tool for deciphering the genetics of Alzheimer disease, and it serves as a potential model for tracking the most viable gene candidates in other genetically complex diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the main genetic risk factor in SAD is the APOE gene [91,92,93,94].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [91]
In the citing paper
“Genome-wide association studies have identified BIN1 within the second most significant susceptibility locus in late-onset Alzheimer’s disease (AD).”
From Predominant expression of Alzheimer’s disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts (2016) · cites this paper as [25]
In the citing paper
“Fifty-two sex-specific KNDs of AD were also known AD genetic risk factors based on the AlzGene database and the genes identified from a large-scale meta-analysis carried out by the International Genomics of Alzheimer’s Project (IGAP)”
From Sex specific molecular networks and key drivers of Alzheimer’s disease (2023) · cites this paper as [46]
In the citing paper
“CLU also known as apolipoprotein J (APOJ), was identified as an AD risk gene by a large scale meta-analysis [46].”
From Sex specific molecular networks and key drivers of Alzheimer’s disease (2023) · cites this paper as [46]
In the citing paper
“Among the AD susceptibility genes/loci identified to date, APOE remains the most significant genetic risk factor across populations.”
From Association of rare APOE missense variants with Alzheimer's disease in the Japanese population (2025) · cites this paper as [9]
In the citing paper
“there is a strong positive correlation between the APOE ε4 allele and Aβ pathology in human AD brains with the highest Aβ burden found in homozygous APOE ε4 carriers”
From ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease (2022) · cites this paper as Bertram et al 2007
In the citing paper
“Since then, numerous studies have confirmed that possession of the ε4 allele is the strongest genetic risk factor for both AD and CAA, or a combination of both disorders (Bertram et al., 2007; Farrer et al., 1997).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Bertram et al., 2007
In the citing paper
“Bridging integrator 1 (BIN1) has been identified as the most important genetic risk factor in LOAD after APOE [475].”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [475]
In the citing paper
“In the most common form of AD, sporadic late-onset AD, many genetic variations contribute to increase or lower risk; greater than 20 have been identified (AlzGene Database; www.alzgene.org).22”
From The Alzheimer’s Disease Clinical Spectrum (2019) · cites this paper as [22]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Comparison of two methods to detect publication bias in meta-analysis.
Peters, J. L. (2006) · JAMA · doi:10.1001/jama.295.6.676 · Cited by 2,278
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Replication validity of genetic association studies
Ioannidis, J. P. A., Ntzani, E., Trikalinos, T. A., & Contopoulos‐Ioannidis, D. G. (2001) · Nature Genetics · doi:10.1038/ng749 · Cited by 1,834
Use and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683
A comprehensive review of genetic association studies
Hirschhorn, J. N., Lohmueller, K., Byrne, E., & Hirschhorn, K. (2002) · Genetics in Medicine · doi:10.1097/00125817-200203000-00002 · Cited by 1,674
Problems of reporting genetic associations with complex outcomes
Colhoun, H. M., McKeigue, P., & Smith, G. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12715-8 · Cited by 1,203
The occurrence of lung cancer in man.
Ml, L. (1953) · PubMed · Cited by 945
Cited by
Sorted by citations
Items 901–1,000 of 1,006
Zepa, L., Frenkel, M., Belinson, H., Kariv-Inbal, Z., Kayed, R., Masliah, E., & Michaelson, D. M. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/792070 · Cited by 23
Schnetz‐Boutaud, N. C., Hoffman, J., Coe, J., Murdock, D. G., Pericak‐Vance, M. A., & Haines, J. L. (2012) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2012.00727.x · Cited by 23
Petrisko, T. J., Gómez-Arboledas, Á., & Tenner, A. J. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.09.003 · Cited by 23
Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk
Ebbert, M., Boehme, K. L., Wadsworth, M. E., Staley, L. A., Initiative, A. D. N., Mukherjee, S., Crane, P. K., Ridge, P. G., & Kauwe, J. S. K. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.08.163 · Cited by 23
Jo, S. A., Ahn, K., Kim, E., Kim, H.-S., Jo, I., Kim, D. K., Han, C., & Park, M. H. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000112918 · Cited by 23
SORL1 gene polymorphism association with late-onset Alzheimer’s disease
Feng, X., Hou, D., Deng, Y., Li, W., Tian, M., & Yu, Z. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.055 · Cited by 23
Zeng, F., Zou, H., Zhou, H., Li, J., Wang, L., Cao, H.-Y., Yi, X., Wang, X., Liang, C., Wang, Y., et al. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.061 · Cited by 23
Liang, W. S., Chen, K., Lee, W., Sidhar, K., Corneveaux, J. J., Allen, A. N., Myers, A., Villa, S., Meechoovet, B., Pruzin, J. J., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.066 · Cited by 23
Capturing Alzheimer's disease genomes with induced pluripotent stem cells: prospects and challenges
Israel, M. A., & Goldstein, L. S. B. (2011) · Genome Medicine · doi:10.1186/gm265 · Cited by 23
Schmitt, O. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000038 · Cited by 23
McFall, G. P., Wiebe, S. A., Vergote, D., Anstey, K. J., & Dixon, R. A. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.08.002 · Cited by 23
Two Alzheimer’s disease risk genes increase entorhinal cortex volume in young adults
DiBattista, A. M., Stevens, B. W., Rebeck, G. W., & Green, A. E. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00779 · Cited by 23
Wruck, W., Schröter, F., & Adjaye, J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150733 · Cited by 23
Detecting hidden batch factors through data-adaptive adjustment for biological effects
Yi, H., Raman, A. T., Zhang, H., Allen, G. I., & Liu, Z. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx635 · Cited by 23
Fisk, H. L., Irvine, M., Miles, E. A., Lietz, G., Mathers, J. C., Packard, C. J., Armah, C. K., Kofler, B. M., Curtis, P. J., Minihane, A. M., et al. (2018) · British Journal Of Nutrition · doi:10.1017/s000711451800106x · Cited by 23
Aladeokin, A. C., Akiyama, T. H., Kimura, A., Kimura, Y., Jitsuki‐Takahashi, A., Nakamura, H., Makihara, H., Masukawa, D., Nakabayashi, J., Hirano, H., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104603 · Cited by 23
Avram, S., Mernea, M., Limban, C., Borcan, F., & Chifiriuc, M. C. (2019) · Current Neuropharmacology · doi:10.2174/1570159x18666191230120053 · Cited by 24
Augustin, R., Lichtenthaler, S. F., Greeff, M., Hansen, J., Wurst, W., & Trümbach, D. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/154325 · Cited by 23
Regulation of amyloid-β production by the prion protein
Jarosz-Griffiths, H., Whitehouse, I. J., & Hooper, N. M. (2012) · Prion · doi:10.4161/pri.18988 · Cited by 23
Association of DAPK1 genetic variations with Alzheimer's disease in Han Chinese
Wu, Z., Zhang, W., Yu, J., Zhang, Q., Tian, Y., Lu, R.-C., Yu, N., Zhao-fu, C., & Tan, L. (2010) · Brain Research · doi:10.1016/j.brainres.2010.12.036 · Cited by 23
Katzorke, A., Zeller, J. B. M., Müller, L. D., Lauer, M., Polak, T. T., Reif, A., Deckert, J., & Herrmann, M. J. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00046 · Cited by 23
Jiang, Q. Y., Shi, D., Nakajima, M., Dai, J. M., Wei, J., Malizos, Κ. Ν., Qin, J., Miyamoto, Y., Kamatani, N., Liu, B., et al. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0216-4 · Cited by 23
Earlier Onset of Alzheimer's Disease: Risk Polymorphisms Within PRNP, PRND, CYP46, and APOE Genes
Golańska, E., Hułas-Bigoszewska, K., Sieruta, M., Zawlik, I., Witusik‐Perkowska, M., Grešner, S. M., Sobów, T., Styczyńska, M., Pepłońska, B., Barcikowska, M., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1055 · Cited by 23
Alzheimer risk loci and associated neuropathology in a population-based study (Vantaa 85+)
Mäkelä, M., Kaivola, K., Valori, M., Paetau, A. E., Polvikoski, T. M., Singleton, A., Traynor, B. J., Stone, D. J., Peuralinna, T., Tienari, P. J., et al. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000211 · Cited by 22
Prokopenko, I., Miyakawa, G., Zheng, B., Heikkinen, J., Petrova, D., Udeh‐Momoh, C. T., Claringbould, A., Neumann, J., Haytural, H., Kaakinen, M., et al. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.08.005 · Cited by 22
Self-citationRETRACTED ARTICLE: Exploring the Role of CLU in the Pathogenesis of Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Begum, M. M., Islam, M. S., Behl, T., & Ashraf, G. M. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00271-4 · Cited by 22
RetractedAlzheimer’s Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer’s Disease
Kuksa, P. P., Liu, C., Fu, W., Qu, L., Zhao, Y., Katanić, Ž., Clark, K., Kuzma, A. B., Ho, P., Tzeng, K., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215055 · Cited by 22
Dementia risk and dynamic response to exercise: A non-randomized clinical trial
Vidoni, E. D., Morris, J. K., Palmer, J. A., Li, Y., White, D., Kueck, P. J., John, C. S., Honea, R. A., Lepping, R. J., Lee, P., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265860 · Cited by 22
Genome-wide association study in Alzheimer’s disease: a bibliometric and visualization analysis
Zhang, J., Wang, Y., Zhang, Y., & Yao, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1290657 · Cited by 22
A review and analysis of key biomarkers in Alzheimer’s disease
Zhang, Z., Liu, X., Zhang, S., Song, Z., Lu, K., & Yang, W. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1358998 · Cited by 22
Hammers, D. B., Eloyan, A., Thangarajah, M., Taurone, A., Beckett, L. A., Gao, S., Polsinelli, A. J., Kirby, K., Dage, J. L., Nudelman, K. N. H., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14218 · Cited by 22
Applying Imaging Genetics to ADHD: the Promises and the Challenges
Wu, Z.-M., Yang, L., & Wang, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8683-z · Cited by 22
Wang, W., Yu, J., Tan, L., Liu, Q., Wang, H.-F., & Ma, X. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.10.015 · Cited by 22
FMRI: Use in Early Alzheimer‘s Disease and in Clinical Trials
Pihlajamaki, M. M., & Sperling, R. A. (2008) · Future Neurology · doi:10.2217/14796708.3.4.409 · Cited by 22
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Floudas, C. S., Um, N., Kamboh, M. I., Barmada, M. M., & Visweswaran, S. (2014) · BioData Mining · doi:10.1186/s13040-014-0035-z · Cited by 22
Han, Z., Qu, J., Zhao, J., & Zou, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-29450-2 · Cited by 22
Differential Methylation Levels in CpGs of the BIN1 Gene in Individuals With Alzheimer Disease
Salcedo-Tacuma, D., Melgarejo, J. D., Mahecha, M. F., Ortega-Rojas, J., Bustos, C., Pardo, R., & Arboleda, H. (2019) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000329 · Cited by 22
Evans, S., Dowell, N. G., Prowse, F., Tabet, N., King, S. L., & Rusted, J. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-59272-0 · Cited by 22
Implication of GAB2 Gene Polymorphism in Italian Patients with Alzheimer's Disease
Nacmias, B., Tedde, A., Bagnoli, S., Cellini, E., Guarnieri, B., Piacentini, S., & Sorbi, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1005 · Cited by 22
Interaction of insulin and PPAR-α genes in Alzheimer’s disease: the Epistasis Project
Kölsch, H., Lehmann, D. J., Ibrahim‐Verbaas, C. A., Combarros, O., van Duijn, C. M., Hammond, N., Belbin, O., Cortina‐Borja, M., Lehmann, M. G., Aulchenko, Y. S., et al. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0732-4 · Cited by 22
Expanded high-resolution genetic study of 109 Swedish families with Alzheimer's disease
Sillén, A., Andrade, J., Lilius, L., Forsell, C., Axelman, K., Odeberg, J., Winblad, B. G., & Graff, C. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201946 · Cited by 22
Neill, D. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.06.004 · Cited by 22
Benetti, F., Gustincich, S., & Legname, G. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.659661 · Cited by 22
Gehlenborg, N., Hwang, D., Lee, I. Y., Yoo, H., Baxter, D. H., Petritis, B. O., Pitstick, R., Marzolf, B., DeArmond, S. J., Carlson, G. A., et al. (2009) · Database · doi:10.1093/database/bap011 · Cited by 22
Mandell, A. M., & Green, R. C. (2011) · Wiley eBooks · doi:10.1002/9781444344110.ch1 · Cited by 22
Evaluation of the Common Molecular Basis in Alzheimer’s and Parkinson’s Diseases
Rana, P., Franco, E. F., Rao, Y., Syed, K., Barh, D., Azevedo, V., Ramos, R. T. J., & Ghosh, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153730 · Cited by 22
Rare ABCA7 variants in 2 German families with Alzheimer disease
May, P., Pichler, S., Hartl, D., Bobbili, D. R., Mayhaus, M., Spaniol, C., Kurz, A., Balling, R., Schneider, J. G., & Riemenschneider, M. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000224 · Cited by 18
Kitzlerová, E., Fišar, Z., Lelková, P., Jirák, R., Zvěřová, M., Hroudová, J., Manukyan, A., Martásek, P., & Raboch, J. (2018) · Medical Science Monitor · doi:10.12659/msm.907202 · Cited by 21
da Rocha, J. F., Lance, M. L., Luo, R., Schlachter, P., Moreira, L., Iqbal, M. A., Kuhn, P., Gardner, R. S., Valaris, S., Islam, M. R., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01971-w · Cited by 22
Deciphering gene-environment interactions through mouse models of allergic asthma
Willis‐Owen, S. A. G., & Valdar, W. S. J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.09.016 · Cited by 21
Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer’s Disease
Seripa, D., Panza, F., Paroni, G., D’Onofrio, G., Bisceglia, P., Gravina, C., Urbano, M., Lozupone, M., Solfrizzi, V., Bizzarro, A., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0547-x · Cited by 21
Cognitive Functioning of U.S. Adults by Race and Hispanic Origin
Díaz-Venegas, C., Downer, B. G., Langa, K. M., & Wong, R. (2018) · Springer eBooks · doi:10.1007/978-3-030-00584-9_5 · Cited by 21
Lee, T., Lee, H., & Initiative, T. A. D. N. (2021) · Biomedicines · doi:10.3390/biomedicines9111525 · Cited by 21
Walker, K. A., An, Y., Moghekar, A., Moaddel, R., Duggan, M. R., Peng, Z., Tian, Q., Pilling, L. C., Drouin, S. M., Espeland, M. A., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00772-2 · Cited by 21
Genomic Privacy Metrics: A Systematic Comparison
Wagner, I. (2015) · IEEE Security and Privacy Workshops (SPW) · doi:10.1109/spw.2015.15 · Cited by 21
Finding a pathological diagnosis for A lzheimer's disease: Are inflammatory molecules the answer?
Bhamra, M. S., & Ashton, N. J. (2012) · Electrophoresis · doi:10.1002/elps.201200161 · Cited by 21
Influence of Alzheimer's disease genes on cognitive decline: the Guangzhou Biobank Cohort Study
Gui, H., Jiang, C. Q., Cherny, S. S., Sham, P. C., Xu, L., Liu, B., Jin, Y. L., Zhu, T., Zhang, W. S., Thomas, G. N., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.022 · Cited by 21
Freude, K., Pires, C., Hyttel, P., & Hall, V. J. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041402 · Cited by 21
Karim, S., Mirza, Z., Ansari, S. A., Rasool, M., Iqbal, Z., Sohrab, S. S., Kamal, M. A., Abuzenadah, A. M., & Al-Qahtani, M. H. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140917113446 · Cited by 21
Woltjer, R. L., Reese, L. C., Richardson, B. E., Tran, H. T. D., Green, S., Pham, T., Chalupsky, M., Gabriel, I., Light, T. J., Sanford, L., et al. (2015) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2015.10.012 · Cited by 21
Zhang, W., Luo, T., Qiu, S., Ye, J., Cai, D., He, X., & Wang, J. (2018) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2018.2816029 · Cited by 21
The Genetics of Alzheimer’s Disease in the Chinese Population
Gan, C., Zhang, T., & Lee, T. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072381 · Cited by 21
Díaz, M. L., Fabelo, N., Casañas‐Sánchez, V., Marín, R., Gómez, T., Quinto‐Alemany, D., & Pérez, J. A. P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150470 · Cited by 21
Looking for novel ways to treat the hallmarks of Alzheimer's disease
Stewart, A. J., Fox, A. W., Morimoto, B. H., & Gozes, I. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.8.1183 · Cited by 21
Llorca, J., Rodríguez‐Rodríguez, E., Dierssen‐Sotos, T., Delgado‐Rodríguez, M., Berciano, J., & Combarros, O. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00899.x · Cited by 21
Practical Issues in Building Risk-Predicting Models for Complex Diseases
Kang, J., Cho, J. H., & Zhao, H. (2010) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400903572829 · Cited by 21
Transgenic Drosophila model to study apolipoprotein E4-induced neurodegeneration
Haddadi, M., Nongthomba, U., Jahromi, S. R., & Ramesh, S. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.022 · Cited by 21
Probing the role of PPARγ in the regulation of late-onset Alzheimer’s disease-associated genes
Barrera, J., Subramanian, S., & Chiba-Falek, O. (2018) · PLOS ONE · doi:10.1371/journal.pone.0196943 · Cited by 21
Medical Anthropology and Mental Health
Kleinman, A. (2012) · Duke University Press eBooks · doi:10.1215/9780822395478-008 · Cited by 22
What is the Human Variome Project?
(2007) · Nature Genetics · doi:10.1038/ng0407-423 · Cited by 21
Liang, Y., Li, H., Lv, C., Shu, N., Chen, K., Li, X., Zhang, J., Hu, L., & Zhang, Z. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.1 · Cited by 20
Genome research in pre-dementia stages of Alzheimer's disease
Moreno–Grau, S., & Ruiz, A. (2016) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2016.12 · Cited by 20
Performance Metrics for Selecting Single Nucleotide Polymorphisms in Late-onset Alzheimer’s Disease
Chen, Y., Hsiao, C.-J., Jung, C.-C., Hu, H., Chen, J.-H., Lee, W., Chiou, J., Chen, T., Sun, Y., Wen, L.-L., et al. (2016) · Scientific Reports · doi:10.1038/srep36155 · Cited by 20
Identifying genetic biomarkers associated to Alzheimer's disease using Support Vector Machine
Hamid, M. M. A. E., Omar, Y. M. K., & Mabrouk, M. S. (2016) · Cairo International Biomedical Engineering Conference · doi:10.1109/cibec.2016.7836087 · Cited by 20
Possible positive effect of the APOE ε2 allele on cognition in early to mid-adult life
Sinclair, L. I., Pleydell-Pearce, C. W., & Day, I. N. M. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.10.008 · Cited by 20
Sapkota, S., & Dixon, R. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170909 · Cited by 20
Yamaguchi‐Kabata, Y., Morihara, T., Ohara, T., Ninomiya, T., Takahashi, A., Akatsu, H., Hashizume, Y., Hayashi, N., Shigemizu, D., Boroevich, K. A., et al. (2018) · Human Genetics · doi:10.1007/s00439-018-1906-z · Cited by 20
AmyCo: the amyloidoses collection
Nastou, K. C., Nasi, G. I., Tsiolaki, P. L., Litou, Z. I., & Iconomidou, V. A. (2019) · Amyloid · doi:10.1080/13506129.2019.1603143 · Cited by 20
Squillario, M., Abate, G., Tomasi, F., Tozzo, V., Barla, A., Uberti, D. L., Initiative, T. A. D. N., Weiner, M. W., Aisen, P. S. S., Petersen, R. C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67699-8 · Cited by 20
Genetic Insights into Alzheimer's Disease
Latimer, C. S., Lucot, K. L., Keene, C. D., Cholerton, B., & Montine, T. J. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032551 · Cited by 20
Role of Amyloid-β–Metal Interactions In Alzheimer‘s Disease
Duce, J. A., Bush, A. I., & Adlard, P. A. (2011) · Future Neurology · doi:10.2217/fnl.11.43 · Cited by 20
Lillenes, M. S., Støen, M., Günther, C., Selnes, P., Stenset, V. T. V., Espeseth, T., Reinvang, I., Fladby, T., & Tønjum, T. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.02.062 · Cited by 20
Nia, B. V., Kang, C., Tran, M. G., Lee, D., & Murakami, S. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00055 · Cited by 20
Exploratory data from complete genomes of familial alzheimer disease age-at-onset outliers
Lalli, M. A., Garcia, G., Madrigal, L., Arcos-Burgos, M., Arcila, M. L., Kosik, K. S., & Lopera, F. (2012) · Human Mutation · doi:10.1002/humu.22167 · Cited by 19
BIN1 localization is distinct from Tau tangles in Alzheimer’s disease
De Rossi, P., Buggia-Prevot, V., Andrew, R., Krause, S., Woo, E., Nelson, P., Pytel, P., & Thinakaran, G. (2017) · Matters · doi:10.19185/matters.201611000018 · Cited by 19
Roeben, B., the TREND study team, Maetzler, W., Vanmechelen, E., Schulte, C., Heinzel, S., Stellos, K., Godau, J., Huber, H., Brockmann, K., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150575 · Cited by 19
Metallothioneins in Prion- and Amyloid-Related Diseases
Adam, P., Křížková, S., Heger, Z., Babula, P., Pekařík, V., Vaculovičová, M., Gomes, C. M., Kizek, R., & Adam, V. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150984 · Cited by 19
Head circumference, apolipoprotein E genotype and cognition in the Bavarian School Sisters Study
Perneczky, R., Alexopoulos, P., Wagenpfeil, S., Bickel, H., & Kurz, A. (2011) · European Psychiatry · doi:10.1016/j.eurpsy.2011.01.008 · Cited by 19
CYP46A1 T/C polymorphism associated with the APOEε4 allele increases the risk of Alzheimer’s disease
Li, L., Yin, Z., Liu, J., Li, G., Wang, Y., Yan, J., & Zhou, H. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6690-4 · Cited by 19
Minihane, A. M. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s0029665112002856 · Cited by 19
Systems Biology Approach for New Target and Biomarker Identification
Wang, I., Stone, D. J., Nickle, D. C., Loboda, A. P., Puig, Ó., & Roberts, C. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_252 · Cited by 19
Vishnu, V. Y., Modi, M., Sharma, S., Mohanty, M., Goyal, M., Lal, V., Khandelwal, N. K., Mittal, B. R., & Prabhakar, S. K. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166369 · Cited by 19
Park, C., Kim, J., Kim, J., & Park, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201056 · Cited by 19
The Cognitive Ageing, Nutrition and Neurogenesis (CANN) trial: Design and progress
Irvine, M. A., Scholey, A. B., King, R., Gillings, R., Vauzour, D., DeMichele, S. J., Das, T., Wesnes, K. A., Sutton, B. P., Cassidy, A., et al. (2018) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.08.001 · Cited by 19
Belbin, O., Morgan, K., Medway, C., Warden, D. R., Cortina‐Borja, M., van Duijn, C. M., Adams, H. H. H., Frank, A., Brookes, K. J., Sánchez‐Juan, P., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181116 · Cited by 19
Lack of association between TNF-α polymorphisms and Alzheimer’s disease in an Italian cohort
Tedde, A., Putignano, A. L., Nacmias, B., Bagnoli, S., Cellini, E., & Sorbi, S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.044 · Cited by 19
Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families
Cuenco, K. T., Friedland, R. P., Baldwin, C. T., Guo, J., Vardarajan, B. N., Lunetta, K. L., Cupples, L. A., Green, R. C., DeCarli, C. S., & Farrer, L. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.014 · Cited by 19
A genome-wide association study of Alzheimer’s disease using random forests and enrichment analysis
Zou, L., Huang, Q., Li, A., & Wang, M. (2012) · Science China Life Sciences · doi:10.1007/s11427-012-4343-6 · Cited by 19
GAB2 is not associated with late-onset Alzheimer’s disease in Chinese Han
Lin, K., Tang, M., Han, H., Guo, Y., Lin, Y., & Ma, C. (2009) · Neurological Sciences · doi:10.1007/s10072-009-0178-8 · Cited by 19
Age and apolipoprotein E ε4 effects on neural correlates of odor memory.
Green, A. J., Cervantez, M. R., Graves, L. V., Morgan, C. D., & Murphy, C. A. (2013) · Behavioral Neuroscience · doi:10.1037/a0031891 · Cited by 19
Metadata
- Authors
- Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E.
- Affiliations
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Bertram, Lars
- Venue
- Nature Genetics
- Published
- 2007-01
- Volume
- 39
- Issue
- 1
- Pages
- 17-23
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2017079501
- Cited by
- 1,857
- References
- 30
- Citations by year
- 2026: 22 · 2025: 36 · 2024: 71 · 2023: 56 · 2022: 57 · 2021: 60 · 2020: 83 · 2019: 91 · 2018: 109 · 2017: 82 · 2016: 99 · 2015: 82 · 2014: 134 · 2013: 135 · 2012: 144
- FWCI
- 62.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD060726)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Alzheimer's disease, genetic association studies, susceptibility genes, APOE ε4, polymorphism, case-control study, odds ratio, ACE, CHRNB2, presenilin 1, MTHFR, TFAM, TF
- MeSH terms
- Alzheimer Disease, Humans, Genetic Linkage, Polymorphism, Genetic, Genetic Heterogeneity, Genetic Predisposition to Disease, Databases, Genetic, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
